Trexquant Investment’s Cantel Medical Corporation CMD Stock Holding History

Trexquant Investment’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-29,003	Closed	-$2.67M	–	1409
2018 Q3	$2.67M	Buy	+29,003	New	+$2.76M	0.2%	154
2017 Q4	–	Sell	-3,704	Closed	-$349K	–	1326
2017 Q3	$349K	Buy	+3,704	New	+$292K	0.09%	409
2016 Q4	–	Sell	-4,181	Closed	-$326K	–	1203
2016 Q3	$326K	Sell	4,181 -1,514	-27%	-$110K	0.07%	443
2016 Q2	$391K	Buy	+5,695	New	+$393K	0.05%	561
2015 Q4	–	Sell	-13,100	Closed	-$742K	–	1364
2015 Q3	$742K	Buy	+13,100	New	+$694K	0.06%	555
2015 Q2	–	Sell	-7,762	Closed	-$368K	–	1332
2015 Q1	$368K	Buy	+7,762	New	+$344K	0.04%	791

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Trexquant Investment's CMD Position: Q4 2018 in Review

Trexquant Investment sold out of Cantel Medical Corporation (CMD) in Q4 2018, closing a stake of 29,003 shares — an estimated $2.67M sold.

Trexquant Investment first reported a position in CMD in Q1 2015 and held it in 6 quarters. The position peaked at $2.67M in Q3 2018. 253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

Trexquant Investment reported no remaining Cantel Medical Corporation position as of Q4 2018 after selling out during the quarter.
Trexquant Investment sold 29,003 Cantel Medical Corporation shares in Q4 2018, an estimated $2.67M.
Trexquant Investment first reported a position in Cantel Medical Corporation in Q1 2015 and held it in 6 quarters.
Trexquant Investment's Cantel Medical Corporation position peaked at $2.67M in Q3 2018.
253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on Trexquant Investment's 13F filing for Q4 2018, filed 13 Feb 2019.